EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sanshen San Formula Hinders Cognitive Function and Pathology in Alzheimer's Disease Through Potentiating the Function of Synapse

Shiquan Chang iD, Nana Ding, Yalin Li, Ying Li, Ziling Tang, Junping Pan, Li Yan, Jiaxu Chen

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Shiquan Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese, Medicine, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Drugs, Chinese Herbal, Synapses, Cognition. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, Huang Zhendong Research Fund for Traditional Chinese Medicine of Jinan University, Guangzhou Basic Research Plan City-School Joint Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease ( AD ) constitutes a devastating neurodegenerative disorder, manifested by amyloid‐β aggregation, phosphorylated tau accumulation, and progressive cognitive deterioration. Current therapeutic interventions remain predominantly symptomatic, underscoring the urgency for more efficacious treatment strategies.

Purpose

This study elucidated the therapeutic potential of Sanshen San (SSS), a traditional Chinese herbal formula encompassing Polygala Radix , Pini Radix in Poria , and Acori Tatarinowii Rhizoma , on cognitive function and AD pathology.

Methods

We implemented both acute Aβ 1‐42 ‐injected mice and 5xFAD transgenic mouse models. The therapeutic efficacy of SSS was assessed through behavioral paradigms including Y‐maze, Novel Object Recognition, and Morris Water Maze. Molecular mechanisms were delineated utilizing RNA sequencing, metabolomics analysis, immunofluorescence staining, Golgi‐Cox staining, transmission electron microscopy, and Western blotting.

Results

Chemical analysis unveiled 10 principal bioactive compounds in SSS. The formula substantially ameliorated cognitive performance in both Aβ 1‐42 ‐injected and 5xFAD mouse models, attenuated Aβ plaque burden, and augmented microglial phagocytosis. SSS safeguarded synaptic integrity, enhanced mitochondrial function, and facilitated autophagy. Transcriptomic and metabolomic analyses demonstrated that SSS predominantly operates by reinstating synaptic transmission and neurotransmitter function, particularly in the dopaminergic system.

Conclusion

SSS efficaciously mitigates AD pathology through potentiating synaptic function, optimizing mitochondrial homeostasis, and restoring neurotransmitter balance, exemplifying a promising multi‐target therapeutic strategy for the treatment of AD .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrugs, Chinese HerbalSynapsesCognitionAnimalsMiceMice, TransgenicAmyloid beta-PeptidesMaleMice, Inbred C57BLDisease Models, AnimalHumansPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseaseSanshen san formulaTraditional Chinese medicineautophagyneuron

Substanzen

Drugs, Chinese HerbalAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide Fragments

Autor:innen und Institutionen

  • Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese, Medicine, Jinan University, Guangzhou, China.
  • College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
  • Guangdong Second Provincial General Hospital, Postdoctoral Research Station of Basic Medicine, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

ORCID-Profile: Shiquan Chang

Förderung

  • Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine
  • Huang Zhendong Research Fund for Traditional Chinese Medicine of Jinan University
  • Guangzhou Basic Research Plan City-School Joint Funding Project

Zitieren

APA

Chang, S., Ding, N., Li, Y., Li, Y., Tang, Z., Pan, J., Yan, L., & Chen, J. (2025). Sanshen San Formula Hinders Cognitive Function and Pathology in Alzheimer's Disease Through Potentiating the Function of Synapse. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70349

Vancouver

Chang S, Ding N, Li Y, Li Y, Tang Z, Pan J, et al. Sanshen San Formula Hinders Cognitive Function and Pathology in Alzheimer's Disease Through Potentiating the Function of Synapse. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70349

BibTeX
@article{Chang2025,
  author = {Chang, Shiquan and Ding, Nana and Li, Yalin and Li, Ying and Tang, Ziling and Pan, Junping and Yan, Li and Chen, Jiaxu},
  title = {Sanshen San Formula Hinders Cognitive Function and Pathology in Alzheimer's Disease Through Potentiating the Function of Synapse},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70349}
}
Kostenlos starten →